KAI-1 Able To Distinguish Chromophobe Renal Cancers From Oncocytoma
Main Category: Urology / NephrologyAlso Included In: Cancer / Oncology
Article Date: 05 Jul 2008 - 0:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
ORLANDO, FL (UroToday.com) - (Reported from the Annual Meeting of the American Urological Association) Researchers showed that KAI-1 can differentiate chromophobe renal cancers from oncocytoma.
Papillary renal cancer with clear cell components is worse than pure papillary tumors.
There was a general trend toward watching small renal masses rather than surgery. Small renal tumors that are destined to be metastatic have a growth rate of 0.74cm/year compared to 0.29cm/year for benign masses.
Patients with multiple tumors in one kidney should undergo partial nephrectomies rather than a radical nephrectomy because there is a high risk the contralateral kidney will develop cancer.
Positive surgical margins on frozen section after a partial nephrectomy does not necessarily lead to a local recurrence. Completion nephrectomy should not be done if a focal positive margin is found on the resected renal mass.
Presented by Edward Messing, MD, at the Annual Meeting of the American Urological Association (AUA) - May 17 - 22, 2008. Orange County Convention Center - Orlando, Florida, USA.
Reported by UroToday.com Contributing Editor David P. Wood, MD
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
Copyright © 2008 - UroToday
Visit our urology / nephrology section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/113913.php>
APA
http://www.medicalnewstoday.com/releases/113913.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



